Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...

A world-first study shows stabilised hyaluronic acid gel can safely protect the rectum during radiation therapy for ...

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides an update on its commercial and operational ...

Telix Pharmaceuticals meets its FY25 revenue target with strong Q4 growth, expanded U.S. launches and ongoing trials.

Global Radiopharmaceuticals Market Size The global Radiopharmaceuticals market revenue was USD 6761 Million in 2022 and is ...

Black Californians are five times more likely than others to die of prostate cancer. Gov. Gavin Newsom vetoed a bill that ...

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.